Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Authors
Shuai Xia,
Бо ЛюChao Wang,
Wei Xu,
Qiaoshuai Lan,
Siliang Feng,
Feifei Qi,
Linlin Bao,
Lanying Du,
Shuwen Liu,
Chuan Qin,
Fei Sun,
Zheng‐Li Shi,
Yun Zhu,
Shibo Jiang,
Lu Lu +14 authors
,
Haibo Liu Tip Tip